human normal immunoglobulin for intravenous use
PolandDrugs containing this active substance
-
The medicinal product is used in adults and children and adolescents for the treatment of antibody deficiencies (replacement therapy) and in the treatment of certain inflammatory diseases, such as immune thrombocytopenia, Guillain–Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN).
Form: solution for infusion
Active substance Dosage human normal immunoglobulin for intravenous use 50 mg/ml ATC: J06BA02
Manufacturer: Kedrion S.p.A.
-
The medicinal product is used for replacement therapy in individuals with congenital or acquired antibody deficiency and in individuals exposed to measles (in situations where vaccination is contraindicated). It may also be used in the treatment of selected autoimmune disorders, such as immune thrombocytopenia (ITP), Kawasaki disease, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN).
Form: solution for infusion
Active substance Dosage human normal immunoglobulin for intravenous use 50 mg/ml ATC: J06BA02
Manufacturer: Octapharma Octapharma AB Octapharma GmbH Octapharma Pharmazeutika Produktionsges.m.b.H.
-
The medicine is used to treat bacterial infections (in conjunction with antibiotics) and for replacement therapy in individuals who have insufficient antibodies due to severe immune system deficiencies.
Form: solution for infusion
Active substance Dosage human normal immunoglobulin for intravenous use 50 mg/ml ATC: J06BA02
Manufacturer: Biotest Pharma GmbH